Medrobotics raises $20M to pursue FDA approval, EU marketing

Medrobotics, a surgical products company focused on medical robotics, raised $20 million in equity financing. The funds will be used to help extend the Medrobotics consumer market in Europe, where it has received CE marks for surgical tools, the Flex System and the Flex Retractor. The Flex System is designed for otolaryngology departments to perform minimally invasive head and neck surgeries. The startup is also gearing up for an expected FDA clearance which would allow it to market its products in the U.S. Release